Tribute and Next Steps in Advanced Spectroscopy for Upstream Bioprocessing
Webinar Overview
Upstream process development greatly benefited over the last 15 years from advancements in the cell media characterization, DoE-supporting automation and adoption of NIR / RAMAN spectroscopic-based methods to further facilitate on-line bioprocess monitoring. This has greatly enhanced the pace at which robust bioprocess can be developed while integrating QbD principles. Building on these foundations, we showcase in this talk how taking advantage of recent innovations in NMR spectroscopy is further contributing to improve bioprocess characterization and monitoring, and look into the future to additional benefits NMR will provide.
Wednesday, 20 August 2025
09:00 AM CEST
What to Expect
- Insights into NMR spectroscopy as a tool to profile and qualify complex and non-defined raw material and cell media.
- Insights into where and how NMR spectroscopy is being applied in upstream bioprocess development.
- Future perspectives on developing and integrating NMR-based methods into Bioprocess Monitoring and Control.
Key Learning Points
- Understand the role of NMR in supporting PAT tools like Raman and NIR in bioprocessing.
- Learn how NMR enables direct quantification, multi-attribute analysis, and process monitoring.
- Explore case studies on spent media analysis and raw material qualification.
- Discover how NMR data supports AI/ML-driven predictive models for process monitoring.
Who Should Attend
This webinar is designed for bioprocess development scientists, engineers, analytical and PAT specialists, as well as professionals in quality, regulatory, and process optimization—and anyone interested in advancing upstream bioprocessing through innovative analytical technologies.
Speaker
Frédéric Girard, PhD.
Senior Director BioPharma Business Unit, Bruker Biospin
Frédéric is a chemist by training and holds a PhD in Molecular Biophysics from the University of Orleans / CNRS. He has been an entrepreneur in the analytical R&D and testing industry for over 20 years, serving the biopharmaceutical sector. He founded Spinnovation Analytical in 2004, which was acquired by Eurofins in 2016. Besides analytical sciences, he has strong experience with GMP and environmental management systems. From 2016 to 2024, he was the managing director for Eurofins Spinnovation, and in 2020, he also joined the Senior Scientific Director program of Eurofins BPT Europe, covering the scope of NMR and solid-state characterization. He joined Bruker BioSpin at the end of 2024 as Senior Director for the Biopharma Business Unit, managing the biopharma market with the support of a team of solution product managers.